Literature DB >> 25458465

Chronic ivacaftor treatment: getting F508del-CFTR into more trouble?

Marcus A Mall1, David N Sheppard2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25458465     DOI: 10.1016/j.jcf.2014.10.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  2 in total

1.  Mutation-specific downregulation of CFTR2 variants by gating potentiators.

Authors:  Radu G Avramescu; Yukari Kai; Haijin Xu; Aurélien Bidaud-Meynard; Andrea Schnúr; Saul Frenkiel; Elias Matouk; Guido Veit; Gergely L Lukacs
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

2.  The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites.

Authors:  Elena K Schneider; Rachel M McQuade; Vincenzo C Carbone; Felisa Reyes-Ortega; John W Wilson; Brenda Button; Ayame Saito; Daniel P Poole; Daniel Hoyer; Jian Li; Tony Velkov
Journal:  ERJ Open Res       Date:  2018-03-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.